“With this transaction, we believe we have significantly strengthened our capabilities to succeed with our strategy,” said Les Cross, chairman and CEO of Alphatec Spine.
More Articles on Orthopedic Devices:
Alphatec Spine 3Q Revenue Drops 1.6%
Alphatec Spine Completes Acquisition of Some Phygen Assets
Alphatec Spine has closed its acquisition of certain assets of Phygen.
